Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yasmin and Metformin for Cardiovascular Risk in PCOS
NCT01581814Phase 3Completed
- Sponsor
- Università Cattolica del Sacro Cuore
- Start
- Oct 2008
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of metformin and drospirenone in polycystic ovary syndrome (PCOS), sponsored by Università Cattolica del Sacro Cuore. Started Oct 2008; status: completed.
02
Drugs
metformindrospirenone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT01581814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01581814.